- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04890951
Hysterectomy Versus Uterine Preservation for Pelvic Organ Prolapse Surgery (HUPPS)
May 31, 2021 updated by: University of Calgary
Prospective Multi-site Cohort Study Investigating Hysterectomy Versus Uterine Preservation for Pelvic Organ Prolapse Surgery: The HUPPS Study
Pelvic organ prolapse (POP) is the descent of pelvic organs into the vagina resulting in bulge symptoms and occurs in approximately 50% of women.
Almost 20% of women will elect surgical correction of this condition by age 85.
Removal of the uterus (hysterectomy) with concomitant vaginal vault suspension is a longstanding practice in POP surgery to address apical (uterine) prolapse.
Yet, contemporary evidence on the merits of this approach relative to preservation of the uterus through suspension is needed to better inform surgical decision-making by patients and their healthcare providers.
The objective of this trial is to evaluate POP-specific health outcomes and service utilization of women electing uterine suspension compared to those electing hysterectomy and vaginal vault suspension for POP surgery up to 1-year post-surgery.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
321
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Erin A Brennand, MD
- Phone Number: 403-944-1636
- Email: Erin.brennand@albertahealthservices.ca
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada
- Recruiting
- Pelvic Floor Clinic
-
Contact:
- Natalie Scime, MSc
- Email: natalie.scime@ucalgary.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Women seeking surgical correction of POP at one of the study sites.
Description
Inclusion Criteria:
- Have diagnosed POP of stage ≥2 using the globally recognized Pelvic Organ Prolapse-Quantification System (POP-Q)
- Elect surgical management of POP
- Demonstrate presence of apical prolapse on clinical exam deemed to require either a hysterectomy and concomitant vaginal vault suspension or uterine suspension to properly address their POP during surgical correction
- Desire no further pregnancy
- Can communicate in English
- Are ≥18 years in age
Exclusion Criteria:
- Prior hysterectomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Uterine Preservation
|
Uterine preservation through suspension
|
Hysterectomy
|
Uterine removal and sewing the vagina upwards
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anatomic failure to correct apical POP
Time Frame: 1 year
|
Descent of the apex (POP-Q point C) equal to or beyond one half of the total vaginal length
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall failure to correct POP
Time Frame: 1 year
|
POP-Q stage ≥2 in any compartment, or re-treatment of POP with physiotherapy, pessary, or repeat surgery
|
1 year
|
Subjective failure to correct POP
Time Frame: 6 weeks; 1 year
|
Patient report of bulge symptoms at 6 weeks or 1 year, using one item on the PFDI-20: "Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?"
|
6 weeks; 1 year
|
Length of surgery (minutes)
Time Frame: Peri-operative
|
Peri-operative
|
|
Estimated blood loss during surgery >500 mL
Time Frame: Peri-operative
|
Peri-operative
|
|
Procedural complications
Time Frame: Peri-operative
|
E.g., peri-operative blood transfusion, visceral injury
|
Peri-operative
|
Post-operative infection
Time Frame: Peri-operative
|
E.g., abscess, urinary tract infection
|
Peri-operative
|
Opioid use in-hospital
Time Frame: Peri-operative
|
Measured by Morphine milliequivalent (mEq)
|
Peri-operative
|
Resumption of spontaneous voiding (days)
Time Frame: Peri-operative
|
Peri-operative
|
|
Length of post-operative stay (days)
Time Frame: Peri-operative
|
Peri-operative
|
|
PROM: Total Pelvic Floor Impact Questionnaire-7 (PFIQ-7) score
Time Frame: 6 weeks; 1 year
|
Change from baseline
|
6 weeks; 1 year
|
PROM: Total POP Incontinence Sexual Questionnaire Revised (PISQ-IR) score
Time Frame: 6 weeks; 1 year
|
Change from baseline
|
6 weeks; 1 year
|
PROM: Total Pelvic Floor Distress Inventory-20 (PFDI-20) score
Time Frame: 6 weeks; 1 year
|
Change from baseline
|
6 weeks; 1 year
|
Presentation at the emergency department
Time Frame: 30 days (any health complaint); 1 year (pelvic floor-related complaint)
|
30 days (any health complaint); 1 year (pelvic floor-related complaint)
|
|
Hospital readmission
Time Frame: 30 days (any health complaint); 1 year (pelvic floor-related complaint)
|
30 days (any health complaint); 1 year (pelvic floor-related complaint)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
December 1, 2024
Study Registration Dates
First Submitted
May 5, 2021
First Submitted That Met QC Criteria
May 12, 2021
First Posted (Actual)
May 18, 2021
Study Record Updates
Last Update Posted (Actual)
June 3, 2021
Last Update Submitted That Met QC Criteria
May 31, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB19-2134
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
Unity Health TorontoUnknownVoiding Dysfunction After Pelvic Organ Prolapse SurgeryCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
-
Nykøbing Falster County HospitalZealand University Hospital; University Hospital, Gentofte, Copenhagen; Copenhagen...UnknownBenign Hysterectomy | Postoperative Pelvic Organ Prolapse | Suspension
-
Mackay Medical CollegeRecruitingPelvic Organ Prolapse | Stage III and IV High Grade Pelvic Organ ProlapseTaiwan
-
Peking Union Medical College HospitalUnknown
-
Gaziosmanpasa Research and Education HospitalRecruitingPatients With Pelvic Organ Prolapse | Pectopexy | Lateral Suspension | Pop-q | Pisq-12Turkey
-
Charles University, Czech RepublicUnknownPelvic Organ Prolapse RecurrenceCzech Republic
Clinical Trials on Hysteropexy
-
Medical University of ViennaRecruitingPelvic Organ Prolapse | ProlapseAustria
-
The Cleveland ClinicStanford University; The Christ Hospital; Medstar Health Research Institute; Women... and other collaboratorsCompletedPelvic Organ ProlapseUnited States, Canada
-
Ataturk UniversityRecruiting
-
Ain Shams UniversityRecruiting
-
Zeynep Kamil Maternity and Pediatric Research and...Completed
-
Ain Shams UniversityCompleted
-
Kantonsspital AarauRecruitingUterus ProlapseSwitzerland
-
Seoul National University HospitalUnknownUterovaginal Prolapse | HysteropexyKorea, Republic of
-
Femke van ZantenUnknownPelvic Organ ProlapseIreland